Philadelphia chromosome-negative acute promyelocytic leukemia manifesting after long-term imatinib treatment for chronic myeloid leukemia: a case report and literature review

Ann Hematol. 2018 Jun;97(6):1105-1109. doi: 10.1007/s00277-018-3263-3. Epub 2018 Feb 6.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Humans
  • Imatinib Mesylate / administration & dosage
  • Imatinib Mesylate / adverse effects*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / metabolism
  • Leukemia, Promyelocytic, Acute* / diagnosis
  • Leukemia, Promyelocytic, Acute* / genetics
  • Leukemia, Promyelocytic, Acute* / metabolism
  • Male
  • Middle Aged
  • Neoplasms, Second Primary* / diagnosis
  • Neoplasms, Second Primary* / genetics
  • Neoplasms, Second Primary* / metabolism
  • Philadelphia Chromosome

Substances

  • Imatinib Mesylate